Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
13F holders, Q1 2023
Institutional positions in Kiora Pharmaceuticals Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +3 vs. Q4 2022
- Shares held
- 83.4K
- −67.8K (−44.9%) vs. Q4 2022
- Total value
- $283.6K
- −$235.3K (−45.3%) vs. Q4 2022
- New holders
- 6
- 1 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $2.91M |
| Q1 2026 | 18 | $654.7K |
| Q4 2025 | 19 | $1.39M |
| Q3 2025 | 17 | $1.71M |
| Q2 2025 | 16 | $2.68M |
| Q1 2025 | 18 | $3.87M |
| Q4 2024 | 16 | $4.16M |
| Q3 2024 | 19 | $5.38M |
| Q2 2024 | 17 | $5.97M |
| Q1 2024 | 24 | $7.87M |
| Q4 2023 | 15 | $159.5K |
| Q3 2023 | 14 | $91.9K |
| Q2 2023 | 18 | $425.2K |
| Q1 2023 | 14 | $283.6K |
| Q4 2022 | 11 | $518.8K |
| Q3 2022 | 9 | $209.0K |
| Q2 2022 | 14 | $391.0K |
| Q1 2022 | 16 | $517.0K |
| Q4 2021 | 13 | $1.22M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Kiora Pharmaceuticals Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 21,460 | $70.0K | 0.00% | +21,460 | New |
| BlackRock Inc. | 14,462 | $48.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 14,134 | $47.2K | 0.00% | +14,134 | New |
| Dimensional Fund Advisors LP | 12,254 | $40.9K | 0.00% | +12,254 | New |
| Bank of Montreal | 10,000 | $40.4K | 0.00% | +10,000 | New |
| Vanguard Group Inc | 10,503 | $35.1K | 0.00% | +10,503 | New |
| GWM Advisors LLC | 200 | $668 | 0.00% | +200 | New |
| UBS Group AG | 166 | $555 | 0.00% | −4,088−96.1% | Reduced |
| US Bancorp | 67 | $224 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 36 | $120 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 11 | $37 | 0.00% | +4+57.1% | Added |
| Morgan Stanley | 8 | $27 | 0.00% | −108−93.1% | Reduced |
| Albion Financial Group | 6 | $21 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 48 | $0 | 0.00% | −4,228−98.9% | Reduced |
| Walleye Capital LLC | 0 | $0 | 0.00% | −83,300−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −33,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −11,679−100.0% | Sold out |